Pesquisas alternativas:
develop type » developing type (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug does (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Kitamoto, Tetsuyuki., International Symposium of Prion Diseases for Food and Drug Safety
Publicado em 2005
“... (vCJD) in the United Kingdom. In 2004, the International symposium of prion diseases for food and drug...”Publicado em 2005
Obter o texto integral
Livro
2
“.... The NFIT devices can be classified based on their working, type of load, mechanism of drug delivery...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Leong, Wen Bun, Nolen, Melissa, Thomas, G. Neil, Adab, Paymanè, Banerjee, Dev, Taheri, Shahrad
Publicado em 2014
“... examined the role of hypoxemia in the development of DM nephropathy in severely obese patients. METHODS...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
Por Jayant, Rahul Dev, Tiwari, Sneham, Atluri, Venkata, Kaushik, Ajeet, Tomitaka, Asahi, Yndart, Adriana, Colon-Perez, Luis, Febo, Marcelo, Nair, Madhavan
Publicado no Sci Rep (2018)
“.... The development of a multi-component [antiretroviral drugs (ARV), latency reactivating agents (LRA) and drug abuse...”Publicado no Sci Rep (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Kushawaha, Pramod K., Gupta, Reema, Tripathi, Chandra Dev Pati, Khare, Prashant, Jaiswal, Anil Kumar, Sundar, Shyam, Dube, Anuradha
Publicado em 2012
“... million people at risk. Due to the non availability of an ideal drug, development of a safe, effective...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Ritchwood, Tiarney D., DeCoster, Jamie, Metzger, Isha, Bolland, John M., Danielson, Carla K.
Publicado no Addict Behav (2016)
“... the consideration of type of SU, and particular combinations of substances, on RSBs in intervention development....”Publicado no Addict Behav (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por De Smedt, Eva, Lui, Hui, Maes, Ken, De Veirman, Kim, Menu, Eline, Vanderkerken, Karin, De Bruyne, Elke
Publicado no Front Oncol (2018)
“... in treatment modalities, MM remains most often incurable due to the development of drug resistance to all...”Publicado no Front Oncol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Ursini, Francesco, Russo, Emilio, Pellino, Gianluca, D’Angelo, Salvatore, Chiaravalloti, Agostino, De Sarro, Giovambattista, Manfredini, Roberto, De Giorgio, Roberto
Publicado no Front Immunol (2018)
“... ago, metformin represents a worldwide milestone in treatment of patients with type 2 diabetes (T2D...”Publicado no Front Immunol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Dienstmann, Rodrigo, De Dosso, Sara, Felip, Enriqueta, Tabernero, Josep
Publicado no Mol Oncol (2011)
“... also improved the efficacy outcomes in KRAS wild‐type colorectal cancer. Nevertheless, a significant...”Publicado no Mol Oncol (2011)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
Por Imbrici, Paola, Liantonio, Antonella, Camerino, Giulia M., De Bellis, Michela, Camerino, Claudia, Mele, Antonietta, Giustino, Arcangela, Pierno, Sabata, De Luca, Annamaria, Tricarico, Domenico, Desaphy, Jean-Francois, Conte, Diana
Publicado no Front Pharmacol (2016)
“... to drugs: this opens the way to a pharmacogenetics strategy, allowing the development of a personalized...”Publicado no Front Pharmacol (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Maíra Rocha Machado, Mariana Celano de Souza Amaral, Matheus de Barros, Ana Clara Klink de Melo
Publicado em 2019-06-01
Assuntos:
“...drug trafficking...”Publicado em 2019-06-01
Obter o texto integral
Artigo
12
Por Jardim, Denis L., de Melo Gagliato, Débora, Giles, Francis J., Kurzrock, Razelle
Publicado no Clin Cancer Res (2017)
“... drug development/approval models on the accuracy of safety and efficacy assessments by searching the US...”Publicado no Clin Cancer Res (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Patricio, B. F. de Carvalho, Albernaz, M. de Souza, Patricio, B. F. de Carvalho, Albernaz, M. de Souza, Santos-Oliveira, R.
Publicado em 2013
“... research directed at developing nanoradiopharmaceuticals based on three different types...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“... termination of drug development or withdrawal of drugs from the market. Management of such interactions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Mariana Rodrigues da Rocha, Sinderlândia Domingas dos Santos, Karine Rafaela de Moura, Lesliane de Sousa Carvalho, Ionara Holanda de Moura, Ana Roberta Vilarouca da Silva
Publicado em 2019-02-01
“... of patients with Type 2 Diabetes Mellitus. Method: Quantitative cross-sectional study developed in five...”Publicado em 2019-02-01
Obter o texto integral
Artigo
16
Por Prajapati, Surendra K, Joshi, Hema, Shalini, Sneh, Patarroyo, Manuel A, Suwanarusk, Rossarin, Kumar, Ashwani, Sharma, Surya K, Eapen, Alex, Dev, Vas, Bhatt, Rajendra M, Valecha, Neena, Nosten, Francois, Rizvi, Moshahid A, Dash, Aditya P
Publicado em 2011
“...BACKGROUND: Multi-drug resistance and severe/complicated cases are the emerging phenotypes of vivax...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Modica de Mohac, Laura, Keating, Alison Veronica, de Fátima Pina, Maria, Raimi-Abraham, Bahijja Tolulope
Publicado no Pharmaceutics (2018)
“...Poor aqueous solubility (<0.1 mg/mL) affects a significant number of drugs currently on the market...”Publicado no Pharmaceutics (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
19
20
“..., the discovery that Schistosoma mansoni also produces haemozoin suggests that new drugs of this type may...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo